Subacute combined degeneration one century later. The neurotrophic action of cobalamin (Vitamin B12) revisited

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 2, 2001, Pages 109-120

  Scalabrino, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; NEUROTROPHIC FACTOR;

ASTROCYTOSIS; CLINICAL FEATURE; CORRELATION FUNCTION; CYANOCOBALAMIN DEFICIENCY; DEMYELINATION; DISEASE ASSOCIATION; HUMAN; NERVE DEGENERATION; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUBACUTE COMBINED DEGENERATION;

EID: 0035101319     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.2.109     Document Type: Review

References (70)

1. Subacute combined degeneration of the spinal cord
2. Beiträge zur kenntnis der im verlauf der perniciözen anämie beobachteten spinalerkrankungen
3. Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking
4. Neurophsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis
5. The myelopathy of pernicious anemia. A neuropathological reappraisal
6. 12 deficiency and subacute combined degeneration of the spinal cord (Funicular Spinal disease)
7. Neuropsychiatric consequences of cobalamin deficiency
8. Neurologic aspects of cobalamin deficiency
9. Inherited disorders of cobalamin transport and metabolism
10. Inherited disorders of cobalamin and folate transport and metabolism
11. The neurology of cobalamin
12. 12) and folate deficiency
13. Cerebrospinal fluid methylmalonic acid concentrations in neurological patients with low and normal serum cobalamin concentrations
14. 12 deficiency
15. Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism
16. 12 absorption following partial gastrectomy
17. Pathology of myelin
18. MRI in subacute combined degeneration
19. 12 deficiency myelopathy
20. 12 deficiency in the elderly
21. 12 and folate
22. Hyperhomocysteinemia and the endocrine system: Implications for atherosclerosis and thrombosis
23. Disorders of homocysteine metabolism
24. 12 deficiency: A new risk factor for breast cancer?
25. Cancer risk following pernicious anaemia
26. Neural-tube defects
27. 12 metabolism in multiple sclerosis
28. Serum cobalamin and methylmalonic acid in Alzheimer dementia
29. 12, and serum total homocysteine levels in confirmed Alzheimer disease
30. Cobalamin deficiency and the pathogenesis of nervous system disease
31. 12, and neuropsychiatric disorders
32. The biochemical basis of neuropathy in cobalamin deficiency
33. Neurological complications of acquired cobalamin deficiency: Caspects
34. 12-dependent enzymes
35. The Yin-Yang of cobalamin biochemistry
36. 12 in the liver and its absorption factor in the stomach: A historical review
37. 12)
38. Membrane receptors for endocytosis in the renal proximal tubule
39. 12 receptor, cubilin, cause hereditary megaloblastic anemia 1
40. 12 complex, mediates high-density lipoprotein holoparticle endocytosis
41. 12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein
42. Mutations in mut methylmalonic acidemia: Clinical and enzymatic correlations
43. The neurologic aspects of transcobalamin II deficiency
44. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: Uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord
45. Animal model for subacute combined degeneration
46. Distal motor axonopathy and central nervous system myelin vacuolation by cycloleucine, an inhibitor of methionine adenosyltransferase
47. 12 deficiency in monkeys
48. 12
49. Subacute combined degeneration and induction of ornithine decarboxylase in spinal cord of totally gastrectomized rats
50. Abnormalities of polyamine biosynthesis in spinal cord of totally gastrectomized rats
51. Subacute combined degeneration in totally gastrectomized rats: An ultrastructural study
52. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction
53. Polyneuropathy due to cobalamin deficiency in the rat
54. Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs
55. Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain
56. Incomplete development of the brain in a newborn with methylmalonic aciduria
57. Selective death of immature neurons in methylmalonic acidemia of the neonate: A case report
58. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated
59. 12 (cobalamin) in the rat central nervous system
60. Therapeutic potential of neurotrophic factors for neurological disorders
61. 12 (Cobalamin) in the rat central nervous system
62. "Inflammatory" cytokines: Neuromodulators in normal brain?
63. Heightened expression of tumor necrosis factor α, interleukin 1α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice
64. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: Potential interaction with epidermal growth factor receptor
65. The role of Bcl-2 expression in EGF inhibition of TNF-α/IFN-γ-induced villous trophoblast apoptosis
66. A new concept in neurodegeneration: TNFα is a silencer of survival signals
67. Glial cells as a model for the role of cobalamin in the nervous system: Impaired synthesis of cobalamin coenzymes in cultured human astrocytes following short-term cobalamin-deprivation
68. Vitamin K-dependent proteins in the developing and aging nervous system
69. Vitamin D